Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.preghy.2021.12.001 http://scihub22266oqcxt.onion/10.1016/j.preghy.2021.12.001 34998223!8653398!34998223     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pregnancy+Hypertens 2022 ; 27 (ä): 103-109 Nephropedia Template TP {{tp|p=34998223|t=2022. sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19 |pdf=|usr=}}{{34998223}} gab.com Text sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19 JO: Pregnancy Hypertens http://www.kidney.de/pget.php?&tw=1&pmid=34998223 #FOAvip OBJECTIVES: To analyze soluble Fms-like tyrosine Kinase 1 (sFlt-1) and Placental Growth Factor (PlGF) ratio concentrations in COVID-19 pregnant patients with and without Hypertensive Disorders of Pregnancy (HDP), compared with non COVID-19 pregnant patients with HDP and a control group. STUDY DESIGN: We recruited and obtained a complete follow-up of 19 COVID-19 pregnant patients with HDP and of 24 COVID-19 normotensive pregnant patients. Demographic, clinical and sFlt-1/PlGF ratio findings were compared with a group of 185 non COVID-19 pregnant patients with HDP and 41 non COVID normotensive patients. Findings were based on univariate analysis and on a multivariate adjusted model, and a case by case analysis of COVID-19 pregnant patients with an abnormal sFlt-1/PlGF ratio > 38 at recruitment. MAIN OUTCOME MEASURES: sFlt-1/PlGF ratio. RESULTS: We confirmed a significant higher prevalence of HDP in women affected by COVID-19 compared to control population. sFlt-1/PlGF ratio was found high in HDP patients, with and without of Sars-Cov2 infection. COVID-19 patients with worse evolution of the disease showed greater rates of obesity and other comorbidities. sFlt/PlGF ratio proved not to be helpful in the differential diagnosis of the severity of this infection. CONCLUSIONS: COVID-19 pregnant patients showed a higher prevalence of HDP compared to non COVID-19 controls, as well as higher comorbidity rates. In spite of the possible common endothelial target and damage, between Sars-Cov-2 infection and HDP, the sFlt1/PlGF ratio did not correlate with the severity of this syndrome. Twit Text FOAVip sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19 ????Pregnancy Hypertens http://www.kidney.de/pget.php?&tw=1&pmid=34998223 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34998223 #FOAvip English Wikipedia <ref>{{Cite pmid|34998223}}</ref> sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19 #MMPMID34998223 Soldavini CM; Di Martino D; Sabattini E; Ornaghi S; Sterpi V; Erra R; Invernizzi F; Tine' G; Giardini V; Vergani P; Ossola MW; Ferrazzi E Pregnancy Hypertens 2022[Mar]; 27 (ä): 103-109 PMID34998223show ga OBJECTIVES: To analyze soluble Fms-like tyrosine Kinase 1 (sFlt-1) and Placental Growth Factor (PlGF) ratio concentrations in COVID-19 pregnant patients with and without Hypertensive Disorders of Pregnancy (HDP), compared with non COVID-19 pregnant patients with HDP and a control group. STUDY DESIGN: We recruited and obtained a complete follow-up of 19 COVID-19 pregnant patients with HDP and of 24 COVID-19 normotensive pregnant patients. Demographic, clinical and sFlt-1/PlGF ratio findings were compared with a group of 185 non COVID-19 pregnant patients with HDP and 41 non COVID normotensive patients. Findings were based on univariate analysis and on a multivariate adjusted model, and a case by case analysis of COVID-19 pregnant patients with an abnormal sFlt-1/PlGF ratio > 38 at recruitment. MAIN OUTCOME MEASURES: sFlt-1/PlGF ratio. RESULTS: We confirmed a significant higher prevalence of HDP in women affected by COVID-19 compared to control population. sFlt-1/PlGF ratio was found high in HDP patients, with and without of Sars-Cov2 infection. COVID-19 patients with worse evolution of the disease showed greater rates of obesity and other comorbidities. sFlt/PlGF ratio proved not to be helpful in the differential diagnosis of the severity of this infection. CONCLUSIONS: COVID-19 pregnant patients showed a higher prevalence of HDP compared to non COVID-19 controls, as well as higher comorbidity rates. In spite of the possible common endothelial target and damage, between Sars-Cov-2 infection and HDP, the sFlt1/PlGF ratio did not correlate with the severity of this syndrome. |Adolescent[MESH] |Adult[MESH] |Biomarkers/blood[MESH] |COVID-19/blood/*complications[MESH] |Case-Control Studies[MESH] |Female[MESH] |Follow-Up Studies[MESH] |Humans[MESH] |Hypertension, Pregnancy-Induced/blood/diagnosis/*virology[MESH] |Multivariate Analysis[MESH] |Placenta Growth Factor/*blood[MESH] |Pregnancy[MESH] |Severity of Illness Index[MESH] |Vascular Endothelial Growth Factor Receptor-1/*blood[MESH]sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients a(epmc).pdf DeepDyve Pubget Overpricing